申请人:American Cyanamid Company
公开号:US04187373A1
公开(公告)日:1980-02-05
This disclosure describes benzanthracene-5,12(or 7,12)-dicarboxaldehyde-bis-hydrazones and the 5,12(or 7,12)-dihydrobenzanthracene-5,12(or 7,12)-dicarboxaldehyde-bis-hydrazones useful as antibacterial agents, for inhibiting the growth of transplanted mouse tumors, and for inducing the regression and/or pallation of leukemia and related cancers.
本文披露了苯并蒽-5,12(或7,12)-二甲酰肼双酰肼及其5,12(或7,12)-二氢苯并蒽-5,12(或7,12)-二甲酰肼双酰肼,可用作抗菌剂,用于抑制移植小鼠肿瘤的生长,以及诱导白血病和相关癌症的退化和/或缓解。